Morocco vs Nepal: Tuberculosis patients living with HIV receiving antiretroviral therapy
Morocco
183 patients
in 2021
Nepal
144 patients
in 2021
Morocco rank
70th
Nepal rank
72nd
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Morocco
- Nepal
How they compare
Morocco currently reports 183 patients against 144 patients in Nepal, a difference of 39 patients.
That makes Morocco's figure about 1.3 times Nepal's.
The two have swapped places 4 times across 12 shared years of data; in 2010 it was Morocco ahead.
Morocco ranks 70th and Nepal ranks 72nd of 183 countries.
Morocco has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Morocco | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 192.4 patients | 144.2 patients | 48.2 patients | Morocco |
| 2020s | 209.5 patients | 128.5 patients | 81 patients | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Morocco or Nepal?
- Morocco, at 183 patients against 144 patients in Nepal as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Morocco and Nepal?
- 39 patients, with Morocco ahead.
- How many years of comparable data are there for Morocco and Nepal?
- 12 years are reported by both, from 2010 to 2021.
- How do Morocco and Nepal rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Morocco ranks 70th and Nepal ranks 72nd of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.